NCT03470649View on ClinicalTrials.gov

Effect of IV Iron Isomaltoside on Postoperative Anemia in Total Knee Arthroplasty Patients

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 29, 2018

Primary Completion Date

April 16, 2019

Study Completion Date

April 17, 2019

Conditions
AnemiaKnee Arthropathy
Interventions
DRUG

Iron Isomaltoside 1000

Iron Isomaltoside 1000 would be intravenously administrated to treatment group after main procedure of total knee arthroplasty.

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT03470649 - Effect of IV Iron Isomaltoside on Postoperative Anemia in Total Knee Arthroplasty Patients | Biotech Hunter | Biotech Hunter